Metastatic prostate cancer in transsexual diagnosed after three decades of estrogen therapy.

Rafal Turo, Samer Jallad, William Richard Cross, Stephen Prescott

Abstract


The incidence of prostate cancer in transsexual patients is very low with only few reported cases. Many years before presenting with prostate cancer, these patients receive hormone ablation as a part of their gender therapy. Their disease is already defined as castrate resistant, and the treatment and follow-up of such patients remains a challenge. We report a case of a male-to-female transgender woman who was diagnosed with metastatic prostate cancer, 31 years post-feminization.

Keywords


prostate; prostate cancer; prostate adenocarcinoma; transgender women; transsexual patient; male-to-female sex reassignment

Full Text:

PDF


DOI: http://dx.doi.org/10.5489/cuaj.175